secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOVIE INC. (BIVI)
CIK:        0001580149
Form:       8-K
Filed at:   2026-11-06T22:10:57+00:00
Accession:  0001520138-26-000460
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

BioVie raises $4.74M in registered direct at $1.60/share; issues 2.96M common warrants at $1.70
--------------------------------------------------------------------------------

- Sold 960,000 shares at $1.60 and 2,002,500 pre-funded warrants at $1.5999 (exercise price $0.0001) to a single healthcare-focused institutional investor.
- Concurrent private placement of 2,962,500 common warrants at $1.70 exercise price, exercisable six months after issuance and expiring 5.5 years from issuance.
- Aggregate gross proceeds ~$4.74M before fees; A.G.P./Alliance Global Partners was sole placement agent with a 7.0% cash fee; net proceeds for working capital and general corporate purposes.
- Company agreed to a 60-day standstill on new equity issuance, a six-month ban on variable-rate transactions, and directors/officers locked up 60 days post-close.
- Offering closed November 5, 2026; shares sold under the Form S-3 shelf (File No. 333-296924); BioVie must file a resale registration for the common warrant shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1580149/000152013826000460/0001520138-26-000460-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1580149/000152013826000460/bivi-20261105_8k.htm
  HTML page:      https://secwatch.observer/filing/0001520138-26-000460

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer